Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Natural Product Reports
|
April 5, 2008
Yatakemycin: total synthesis, DNA alkylation, and biological properties
Mark S Tichenor, Dale L Boger
Journal of the American Chemical Society
|
July 9, 2004
Total synthesis, structure revision, and absolute configuration of (+)-yatakemycin
Mark S Tichenor, David B Kastrinsky, Dale L Boger
Journal of Medicinal Chemistry
|
May 21, 2015
Functional Profiling of 2-Aminopyrimidine Histamine H4 Receptor Modulators
Mark S Tichenor, Robin L Thurmond, Jennifer D Venable, et al.
Journal of the American Chemical Society
|
December 7, 2006
Asymmetric total synthesis of (+)- and ent-(-)-yatakemycin and duocarmycin SA: evaluation of yatakemycin key partial structures and its unnatural enantiomer
Mark S Tichenor, John D Trzupek, David B Kastrinsky, et al.
Journal of the American Chemical Society
|
August 19, 2007
Systematic exploration of the structural features of yatakemycin impacting DNA alkylation and biological activity
Mark S Tichenor, Karen S MacMillan, John D Trzupek, et al.
ACS Medicinal Chemistry Letters
|
November 19, 2021
Novel Reagent Space: Identifying Unorderable but Readily Synthesizable Building Blocks
Mark Seierstad, Mark S Tichenor, Renee L DesJarlais, et al.
Journal of the American Chemical Society
|
October 24, 2007
Rational design, synthesis, and evaluation of key analogues of CC-1065 and the duocarmycins
Mark S Tichenor, Karen S MacMillan, James S Stover, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 19, 2016
The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors
John M Keith, Mark S Tichenor, Richard L Apodaca, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 13, 2012
Heteroaryl urea inhibitors of fatty acid amide hydrolase: structure-mutagenicity relationships for arylamine metabolites
Mark S Tichenor, John M Keith, William M Jones, et al.
Journal of Medicinal Chemistry
|
March 6, 2020
Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel Disease
Kristi A Leonard, Lisa A Madge, Paul J Krawczuk, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Natural Product Reports
|
April 5, 2008
Yatakemycin: total synthesis, DNA alkylation, and biological properties
Mark S Tichenor, Dale L Boger
Journal of the American Chemical Society
|
July 9, 2004
Total synthesis, structure revision, and absolute configuration of (+)-yatakemycin
Mark S Tichenor, David B Kastrinsky, Dale L Boger
Journal of Medicinal Chemistry
|
May 21, 2015
Functional Profiling of 2-Aminopyrimidine Histamine H4 Receptor Modulators
Mark S Tichenor, Robin L Thurmond, Jennifer D Venable, et al.
Journal of the American Chemical Society
|
December 7, 2006
Asymmetric total synthesis of (+)- and ent-(-)-yatakemycin and duocarmycin SA: evaluation of yatakemycin key partial structures and its unnatural enantiomer
Mark S Tichenor, John D Trzupek, David B Kastrinsky, et al.
Journal of the American Chemical Society
|
August 19, 2007
Systematic exploration of the structural features of yatakemycin impacting DNA alkylation and biological activity
Mark S Tichenor, Karen S MacMillan, John D Trzupek, et al.
ACS Medicinal Chemistry Letters
|
November 19, 2021
Novel Reagent Space: Identifying Unorderable but Readily Synthesizable Building Blocks
Mark Seierstad, Mark S Tichenor, Renee L DesJarlais, et al.
Journal of the American Chemical Society
|
October 24, 2007
Rational design, synthesis, and evaluation of key analogues of CC-1065 and the duocarmycins
Mark S Tichenor, Karen S MacMillan, James S Stover, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 19, 2016
The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors
John M Keith, Mark S Tichenor, Richard L Apodaca, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 13, 2012
Heteroaryl urea inhibitors of fatty acid amide hydrolase: structure-mutagenicity relationships for arylamine metabolites
Mark S Tichenor, John M Keith, William M Jones, et al.
Journal of Medicinal Chemistry
|
March 6, 2020
Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel Disease
Kristi A Leonard, Lisa A Madge, Paul J Krawczuk, et al.
Page
of 2